Community-Acquired Pneumonia (CAP)
Infectious Disease·MeSH: Pneumonia
3 drugs in development·2 companies·3 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| ZEVTERA® | Innoviva, Inc. (INVA) |
Phase 3(1)
| Drug | Company |
|---|---|
| agent-797 | ImmunityBio, Inc. (IBRX) |
Phase 1(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Community-Acquired Pneumonia (CAP)?
BioSniper tracks 3 drugs in development for Community-Acquired Pneumonia (CAP) across 2 companies.
How many clinical trials target Community-Acquired Pneumonia (CAP)?
There are 3 clinical trials targeting Community-Acquired Pneumonia (CAP) tracked by BioSniper.
Deep-dive into Community-Acquired Pneumonia (CAP)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis